Skip to main content
. 2021 Nov 27;74(1):229–240. doi: 10.1007/s43440-021-00341-0

Fig. 1.

Fig. 1

Consort flow chart of the study. 144 out of 182 patients were allocated to the low-dose, intermediate-dose or high-dose group. Finally, 47, 40 and 46 patients in the low-dose, intermediate and high-dose groups completed the study, respectively